312 related articles for article (PubMed ID: 35603151)
1. Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Xu Y; Du Y; Zheng Q; Zhou T; Ye B; Wu Y; Xu Q; Meng X
Front Immunol; 2022; 13():895110. PubMed ID: 35603151
[TBL] [Abstract][Full Text] [Related]
2. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
4. A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer.
Zhang Y; Liang Y; Wang Y; Ye F; Kong X; Yang Q
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36222299
[TBL] [Abstract][Full Text] [Related]
5. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N
Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228
[No Abstract] [Full Text] [Related]
6. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
Wang Y; Xu Y; Zhang Y
Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765
[TBL] [Abstract][Full Text] [Related]
7. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.
Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X
Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861
[TBL] [Abstract][Full Text] [Related]
9. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
12. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
13. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
[TBL] [Abstract][Full Text] [Related]
14. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
Li XF; Fu WF; Zhang J; Song CG
BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma.
Sae-Fung A; Mutirangura A; Jitkaew S
Front Immunol; 2022; 13():1051273. PubMed ID: 36733386
[TBL] [Abstract][Full Text] [Related]
16. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer.
Zhang J; Wang X; Zhang Z; Ma F; Wang F
Sci Rep; 2024 Mar; 14(1):5339. PubMed ID: 38438469
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes.
Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Jiang S; Zhang W; Zhong C
Sci Rep; 2022 Aug; 12(1):13766. PubMed ID: 35962042
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909
[TBL] [Abstract][Full Text] [Related]
20. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]